A Phase 1 Clinical Study to Evaluate the Safety of Allogeneic Adipose-derived Stem Cells in the Subjects With Crohn's Disease
Phase of Trial: Phase I
Latest Information Update: 12 Jan 2018
At a glance
- Drugs Adipose stem cell therapy Anterogen (Primary)
- Indications Crohn's disease
- Focus Adverse reactions
- Sponsors Anterogen
- 08 Jan 2018 Planned End Date changed from 1 Dec 2016 to 1 Sep 2018.
- 08 Jan 2018 Planned primary completion date changed from 1 Sep 2016 to 1 Jun 2018.
- 24 Oct 2015 New trial record